Medicare Enrolled

Dr. Peter Seraphin, DO

Gastroenterology · Hinsdale, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
12 SALT CREEK LN, Hinsdale, IL 60521
6307892260
In practice since 2006 (19 years)
NPI: 1831204734 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Seraphin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Seraphin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Seraphin

Dr. Peter Seraphin is a gastroenterology specialist in Hinsdale, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Seraphin performed 1,421 Medicare services across 1,119 unique beneficiaries.

Between the years covered by Open Payments, Dr. Seraphin received a total of $4,940 from 38 pharmaceutical and/or device companies across 263 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Seraphin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 11% volume in IL $4,940 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,421
Medicare services
Top 11% in IL for gastroenterology
1,119
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~75 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
472 $65 $200
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
172 $96 $212
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
165 $217 $1,425
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
110 $108 $300
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
91 $67 $924
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
70 $140 $407
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
67 $122 $328
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
60 $79 $900
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
46 $191 $1,434
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
35 $189 $1,415
Esophageal dilation with guide wire and endoscope
A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage.
34 $114 $750
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
34 $109 $1,245
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
28 $143 $1,175
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
15 $82 $250
Endoscopic control of upper GI bleeding
A flexible endoscope is used to locate and stop bleeding in the esophagus, stomach, or upper small intestine.
11 $167 $1,150
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
11 $71 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,940
Total received (2018-2024)
Avg $706/year across 7 years
Top 27% in IL for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
263
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,940 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$510
2023
$777
2022
$902
2021
$820
2020
$173
2019
$1,161
2018
$597

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$97
Janssen Biotech, Inc.
$64
Lilly USA, LLC
$51
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$48
Ardelyx, Inc.
$44
GENZYME CORPORATION
$36
Merck Sharp & Dohme LLC
$35
Gilead Sciences, Inc.
$30
RedHill Biopharma Inc.
$27
ABBVIE INC.
$21
Sandoz Inc.
$20
Celgene Corporation
$19
Ipsen Biopharmaceuticals, Inc
$18
Top 3 companies account for 41.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$840
Takeda Pharmaceuticals U.S.A., Inc.
$646
AbbVie Inc.
$541
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$464
PFIZER INC.
$414
Gilead Sciences, Inc.
$264
ABBVIE INC.
$242
AbbVie, Inc.
$207
Shire North American Group Inc
$144
GENZYME CORPORATION
$110
Celgene Corporation
$105
QOL Medical, LLC
$77
Braintree Laboratories, Inc.
$76
Ardelyx, Inc.
$73
RedHill Biopharma Inc.
$63
Allergan Inc.
$59
Merck Sharp & Dohme LLC
$59
Evoke Pharma, Inc.
$53
Lilly USA, LLC
$51
Ferring Pharmaceuticals Inc.
$49
INTERCEPT PHARMACEUTICALS, INC.
$45
PENTAX of America, Inc.
$36
Ironwood Pharmaceuticals, Inc
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Alfasigma USA, Inc.
$22
Nestle HealthCare Nutrition Inc.
$22
EVOKE PHARMA, INC.
$20
Organon LLC
$20
VIVUS LLC
$20
Sandoz Inc.
$20
Prometheus Laboratories Inc.
$20
UCB, Inc.
$19
Daiichi Sankyo Inc.
$18
Ipsen Biopharmaceuticals, Inc
$18
Intercept Pharmaceuticals, Inc.
$18
W. L. Gore & Associates, Inc.
$17
Synergy Pharmaceuticals Inc
$15
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 41.0% of all-time payments
Associated products mentioned in payments ›
Amitiza · C2 CryoBalloon · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EOHILIA · Entyvio · GATTEX · GIMOTI · GORE CARDIOFORM Septal Occluder · HUMIRA · HYRIMOZ · Humira · IBSRELA · INJECTAFER · IQIRVO · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Motegrity · Mydayis · OCALIVA · OMVOH · PANCREAZE · REBYOTA · RELISTOR · RENFLEXIS · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP · SUTAB · Sucraid · TRULANCE · Talicia · Trulance · UCERIS · UCERIS TABLETS · VIBERZI · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in Hinsdale?
Compare gastroenterologists in the Hinsdale area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
478
Per 100K population
51.5
County median income
$110,502
Nearest hospital
UCHICAGO MEDICINE ADVENTHEALTH HINSDALE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Seraphin is a clinical cardiology specialist, with above-average Medicare volume (top 11% in IL), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Seraphin experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Seraphin performed 472 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Seraphin receive payments from pharmaceutical companies?
Yes. Dr. Seraphin received a total of $4,940 from 38 companies across 263 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Seraphin's costs compare to other gastroenterologists in Hinsdale?
Dr. Seraphin's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Seraphin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →